Mr Ken Drazan

KANDO id: 16946

Bio

Ken oversees Healthcare Services investments. Previously, Ken was the CEO and founder of Arginox Pharmaceuticals. Earlier in his career, Ken was a leading academic liver transplant surgeon and basic scientist at Stanford University and UCLA. Ken currently serves as Chairman of Arginox Pharmaceuticals and Kuratek Incorporated. State University of New York, Doctor of Medicine, cum laude. Yale University, Bachelor of Arts in Economics, cum laude.

Education